Santhera Pharmaceuticals Holdings Ltd. revenue breakdown overview

Santhera Pharmaceuticals Holdings Ltd. revenue for the last year amounted to 43.05 M USD, the most of which — 43.07 M USD — came from its highest performing source at the moment, Specialty Niche Products, the year earlier bringing 122.83 M USD. The greatest contribution to the revenue figure was made by Europe — last year it brought Santhera Pharmaceuticals Holdings Ltd. 16.48 M USD, and the year before that — 4.04 M USD.